SV Health Investors, a prominent healthcare-focused private equity firm, is excited to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. In this role, A.J. will continue to lead investments, oversee the SV portfolio, and contribute to the firm’s expansion efforts within the healthcare sector.
SV Health Investors, a leading healthcare-focused private equity firm, is proud to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. Since joining the firm in 2022, A.J. has been instrumental in shaping the firm’s successful investment strategy, with a focus on identifying high-impact opportunities in the healthcare sector. His deep understanding of market dynamics, combined with a strong track record of working closely with portfolio companies to drive growth, has significantly contributed to the value creation and operational success of SV’s investments.
Greg Madden, Managing Partner at SV Health Investors, expressed excitement about A.J.’s promotion, stating, “We are thrilled to announce A.J.’s promotion to Partner. His dedication, expertise, and collaborative approach have made a lasting impact on our firm and the companies we work with. A.J. has consistently demonstrated leadership and vision in identifying and nurturing healthcare companies with transformative potential, and we look forward to seeing him continue to thrive in this expanded role.”
In his new role, A.J. will continue to lead investments and manage SV’s portfolio. Additionally, he will play an active part in shaping the firm’s strategic direction, working closely with the leadership team and other partners to strengthen SV’s position as a key player in the healthcare private equity space. A.J. expressed his enthusiasm for his new role, saying, “I am honored to take on this new position and to continue working with such a talented and dedicated team. SV Health Investors has been a catalyst for positive change in healthcare, and I look forward to accelerating that mission as we partner with innovative companies shaping the future of the industry.”
A.J. brings extensive experience in healthcare investing, having worked on a diverse range of transactions across healthcare services, outsourced medical device and pharmaceutical services, and healthcare IT. His involvement with healthcare board directorships and portfolio companies includes Robling Medical, Packaging Compliance Labs, Hightop Health, Nira Medical Group, Ria Health, Medbio, Velosity, and HemaSource. Prior to joining SV Health Investors, A.J. was a Principal and co-lead of the healthcare sector at private equity firm Graham Partners. He holds a bachelor’s degree from the University of Pennsylvania.
SV Health Investors, founded in 1993, is a private equity firm that specializes in investments within the healthcare and life sciences sectors. With offices in Boston and London, the firm manages approximately $2.0 billion across various investment strategies. SV’s dedicated healthcare Growth-Buyout strategy seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies in sectors such as healthcare services, outsourced medtech and pharma services, medical products, and healthcare IT. By leveraging decades of experience in healthcare transactions and operations, SV aims to create long-term value while advancing the triple aim of healthcare: higher quality care, accessible to more patients, at a lower cost.
